Within 1 day
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Serum (preferred) or plasma
0.7 mL (Note: This volume does not allow for repeat testing.)
Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube. Do not use oxalate, EDTA, or citrate plasma.
Separate serum or plasma from cells within 45 minutes of collection.
High BUN occurs in chronic glomerulonephritis, pyelonephritis and other causes of chronic renal disease; with acute renal failure, decreased renal perfusion (prerenal azotemia) as in shock. With urinary tract obstruction BUN increases (postrenal azotemia), for example as caused by neoplastic infiltration of the ureters, hyperplasia or carcinoma of the prostate. BUN is useful to follow hemodialysis and other therapy. “Uremia” was defined by Luke as an expression of a constellation of signs and symptoms in patients with severe azotemia secondary to acute or chronic renal failure.1 Causes of increased BUN include severe congestive heart failure, catabolism, tetracyclines with diuretic use, hyperalimentation, ketoacidosis, and dehydration as in diabetes mellitus, but even moderate dehydration can cause BUN to increase. Corticosteroids tend to increase BUN by causing protein catabolism. Bleeding from the gastrointestinal tract is an important cause of high urea nitrogen, commonly accompanied by elevation of BUN:creatinine ratio. Nephrotoxic drugs must be considered.
Borderline high values may occur after recent ingestion of high protein meal and muscle wasting may cause an elevation as well.
With creatinine, BUN is used to monitor patients on dialysis.
Low BUN occurs in normal pregnancy, decreased protein intake, with intravenous fluids, with some antibiotics, and in some but not all instances of liver disease.
As described by DeCaux et al in 1980, in the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): findings include hyponatremia with serum or plasma Na+ ≤128 mmol/L, hypo-osmolality (<260 mOsm/kg with urine osmolality >300 mOsm/kg) with low BUN. Such findings occur in situations in which patients are overhydrated. Clinical findings included absence of edema or evidence of heart, liver, thyroid, renal or adrenal disease.2 Hypouricemia, with uric acid levels in 16 of 17 patients <4 mg/dL, is reported with the syndrome of inappropriate secretion of antidiuretic hormone.3 (SIADH can be seen with higher serum sodiums and higher osmolalities. Urine osmolality is greater than serum osmolality in SIADH. DeCaux in 1982 presented criteria modified from the 1980 paper.4)
Osmolality (mOsm/kg H2O) is calculated as follows:
Osmolality = [Na+ (mmol/L)] x [2 + glucose (mg/dL)] / 18 + [BUN (mg/dL) / 2.8]
Uremia is best evaluated with creatinine as well as urea nitrogen.1 In both prerenal and postrenal azotemia, for instance, BUN is apt to be increased somewhat more than is creatinine; however, in a series of dehydrated children with gastroenteritis who had metabolic acidosis and increased anion gap, 88% had BUN concentration ≤18 mg/dL. The authors found bicarbonate and anion gap more sensitive indices in this setting.5 In chronic progressive renal disease, about three-quarters of the renal parenchyma must be damaged or destroyed before azotemia develops.
Although creatinine is generally considered a more specific test to evaluate renal function, they are commonly used together.1 Luke points out that clinical renal failure is variable between individual patients.1 Drug effects have been summarized.6
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf